International Clinical Trial: The Effect of Adjuvant Topical Estriol Therapy in Postmenopausal Women with Overactive Bladder (OAB) Receiving Solifenacin Treatment

Geneva, Aug. 6 -- International Clinical Trials Registry received information related to the study (TCTR20260731009) titled 'The Effect of Adjuvant Topical Estriol Therapy in Postmenopausal Women with Overactive Bladder (OAB) Receiving Solifenacin Treatment' on July 31.

Study Type: Interventional

Study Design: Randomized

Primary Sponsor: Dzicky Rifqi Fuady (Researcher)

Condition: Overactive Bladder Postmenopausal Women Overactive Bladder, Solifenacin, Topical Estriol, OABSS, IIQ-7 Overactive Bladder, Solifenacin, Topical Estriol, OABSS, IIQ-7

Intervention: Subjects were instructed to apply a topical intravaginal estriol cream (Ovestin). The application schedule mirrored the control group, requiring daily application for the initi...